ChloraPrep One-Step approval
This article was originally published in The Tan Sheet
Executive Summary
Topical antiseptic consisting of chlorhexidine gluconate 2% and isopropyl alcohol 70% for preparation of skin prior to injection approved by FDA Oct. 7. NDA 21-555 was submitted on behalf of Medi-Flex Hospital Products by its agent, Beckloff Associates. In July 2000, agency approved the formulation as an OTC pre-operative skin prep (1"The Tan Sheet" July 24, 2000, In Brief). In April, FDA gave the nod to supplemental NDA 20-832/SCS-002 to change the ampoule size and volume and incorporate labeling changes on the pre-op skin preparation...
You may also be interested in...
ChloraPrep One-Step NDA
FDA approves NDA for chlorhexidine gluconate 2% and isopropyl alcohol 70% preoperative skin preparation July 14. The OTC topical antiseptic is indicated for professional use, the agency notes in its letter to Overland Park, Kan.-based Medi-Flex Hospital Products, finding "adequate information has been presented to demonstrate that the drug product is safe and effective for use"
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.